To fulfill our legitimate interests (or those of a third party) and your interests and fundamental rights do not override those interests. We have put in place procedures to deal with any suspected Personal Information breach and will notify you and any applicable regulator of a breach where we are legally required to do so. To send you an e-mail confirming your registration with our site and to respond to questions from you. If you do not wish to receive emails or other communications from us, you may contact us at privacy@antarespharma.com and request that your Personal Information be removed from our list. Reported fourth quarter 2019 earnings per share of $0.03. Annual balance sheet by MarketWatch. To perform the contract we are about to enter into or have entered into with you. Fourth quarter royalty revenue was $6.2 million as compared to $3.5 million reported in the same period last year, a 78% increase. Who bought or sold Antares Pharma this quarter? Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Antares Pharma, Inc.. Investor Contacts. Senior Product Development Engineer. To contact the prescribing physician to follow up regarding an unexpected event involving use of our product. Antares will not sell your Personal Information or Health-related Personal Information. Please note that, while we make reasonable efforts to comply with such requests, deletion of your personal information does not ensure complete and comprehensive removal of that data from all systems. Partnering with Antares; Devices; For Investors. Cash, cash equivalents and short-term investments were $45.7 million at December 31, 2019, as compared to $41.9 million at September 30, 2019 and $27.9 million at December 31, 2018. Antares Pharma Inc. Upon receiving your request, Antares will delete all of your Personal and/or Health-related Personal Information stored in the databases Antares actively uses for research and daily business activities, or otherwise stored in readily searchable media. A copy of Antares Pharma, Inc.’s (the “Company”) updated investor presentation slides that the Company intends to use effective immediately is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 7.01 by reference. The security of your data is very important to Antares. When you connect to a website that is linked to our Site, we encourage you to read the privacy statements of that website. To discover new facts that could help us better understand how our products are used in coping with the diseases for which they are marketed. Your exercise of these rights will have no adverse effect on the price and quality of our services. Please be aware that Antares may not comply with a consumer’s request to amend or remove information that was provided to Antares by a health care professional or a consumer regarding an adverse drug event. In 2019, we generated significant...Read more, The increase in selling, general...Read more, Sales and marketing expenses nearly...Read more, However, we reported net losses...Read more, In assessing our revenue arrangements...Read more, The significant increase in royalty...Read more, This standard will be effective...Read more, The increases in product revenue...Read more, Cash used in operating activities...Read more, This standard replaces the incurred...Read more, The guidance is effective for...Read more, Revenue is recognized when or...Read more, Based on this determination, the...Read more, The original effective date for...Read more, These arrangements are often complex...Read more, Prescriptions and sales of XYOSTED...Read more, We also received cash proceeds...Read more, The following table presents our...Read more, Fluctuations in our gross profit...Read more, Antares Pharma, Inc. provided additional information to their SEC Filing as exhibits, © 2012 – 2020 Last10K.com All Rights Reserved. View real-time stock prices and stock quotes for a full financial overview. Roger G. Harrison, Ph.D., was appointed to the position of Chief Executive Officer of Antares Pharma, Inc., effective March 12, 2001. 2016-08-09: EX-10.6 Are you researching Antares Pharma (NASDAQ:ATRS) stock for your portfolio? Antares Pharma Inc files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.Antares Pharma Inc is a specialty pharmaceutical company. Antares Pharma, Inc. (Exhibit 10.54 to 10-K/A) April 10, 2018 Downloads We reserve the right to change the terms of this Privacy Statement at any time by posting revisions to our site. Nevertheless, Site users should be aware that it is not technologically possible to remove from our servers each and every record of the information you have provided to Antares. 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. Average salaries for Antares Pharma Product Development Engineer: $99,527. 41-1350192: 100 Princeton South, Suite 300, Ewing, NJ 08628 . We have implemented appropriate security measures, including encryption practices, to prevent your Personal Information and Health-related Personal Information from being accidentally lost, used or accessed in an unauthorized way, altered or disclosed. If we allow a third party contractor to have access to your Personal Information or health-related personal information, we will not authorize them to take it or use it for any purpose that is not consistent with this Privacy Statement. Annual stock financials by MarketWatch. The Site is not designed for, or intentionally targeted at, children under 13 years of age. This site ©2020 Antares Pharma. Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference Provided by GlobeNewswire Sep 8, 2020 12:00 PM UTC Sponsor Center Registrant’s telephone number, including area code: (609) 359-3020 . Employer Identification No.) 02/28/20 10-K Annual Report. Personal Information That You Voluntarily Provide. SC 13G/A - ATRS / Antares Pharma, Inc. / BlackRock Inc. About $113K - $123K/yr Avg. Create an account, Consolidated Balance Sheets (Parenthetical), Consolidated Statements Of Comprehensive Loss, Consolidated Statements Of Stockholders' Equity, Summary Of Significant Accounting Policies, Revenues, Significant Customers And Concentrations Of Risk, Summary Of Significant Accounting Policies (Policies), Summary Of Significant Accounting Policies (Tables), Accrued Expenses And Other Liabilities (Tables), Revenues, Significant Customers And Concentrations Of Risk (Tables), Quarterly Financial Data (Unaudited) (Tables), Summary Of Significant Accounting Policies - Additional Information (Detail), Summary Of Significant Accounting Policies - Inventories (Detail), Summary Of Significant Accounting Policies - Components Of Equipment, Molds, Furniture, And Fixtures (Detail), Summary Of Significant Accounting Policies - Summary Of Changes In Reserves For Product Returns And Sales Allowances (Detail), Summary Of Significant Accounting Policies - Additional Information (Detail1), Leases - Summary Of Operating Lease Maturities (Detail), Leases - Summary Of Future Minimum Lease Payments Under Operating Leases (Detail), Accrued Expenses And Other Liabilities - Schedule Of Accrued Expenses And Other Liabilities (Detail), Long-Term Debt - Additional Information (Detail), Long-Term Debt - Schedule Of Future Principal Payments Under Term Loan, Including End Of Term Charge (Detail), Stockholders' Equity - Additional Information (Detail), Share Based Compensation - Additional Information (Detail), Share Based Compensation - Summary Of Stock Option Activity (Detail), Share Based Compensation - Assumptions Used In Fair Value Measurement Of Options Granted (Detail), Share Based Compensation - Schedule Of Performance Stock Unit Awards And Restricted Stock Granted Under Long-Term Incentive Program (Detail), Share Based Compensation - Fair Value Of Psus Granted Determined Using Monte Carlo Simulation (Detail), Share Based Compensation - Summary Of Share Based Compensation Allocation Expense (Detail), Employee 401(K) Savings Plan - Additional Information (Detail), Sale Of Assets - Additional Information (Detail), Income Taxes - Additional Information (Detail), Income Taxes - Schedule Of Income (Loss) Before Income Tax Domestic And Foreign (Detail), Income Taxes - Summary Of Effective Tax Rates Differ From Statutory Income Tax Rates (Detail), Income Taxes - Summary Of Deferred Tax Assets (Liabilities) (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Revenue Disaggregated By Major Types And Sources (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Revenues Disaggregated By Customer Geographic Location (Detail), Revenues, Significant Customers And Concentrations Of Risk - Summary Of Significant Customers From Which The Company Derived 10% Or More Of Total Revenue (Detail), Quarterly Financial Data (Unaudited) - Quarterly Financial Data (Detail), Exhibit 4.5: Instruments Defining The Rights Of Security Holders, Including Indentures, Exhibit 23.1: Consents Of Experts And Counsel, Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification, Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification, https://last10k.com/sec-filings/atrs/0001564590-20-008465.htm. Investor Contacts. Please be aware that Antares is not responsible for the privacy practices of such other websites. Employer Identification No. The need to back-up our systems to protect information from inadvertent loss means that a copy of information about you or your health-related interests may exist in non-erasable forms that will be difficult or impossible for us to locate. Antares Pharma (Issuer) Powell Fred M (Reporting) Form 4 Statement of changes in … Our Culture and Our People; Antares Benefits; Open Positions; Contact Us By submitting any such information, you represent and warrant that you have obtained your patient’s authorization to do so. Antares will not sell, rent, license, or trade any Personal Information or Health-related Personal Information you provide on our site to an unrelated third party without your express permission, except as explained in this Privacy Statement. Antares is committed to protecting the privacy of users of this website located at www.antarespharma.com or any website owned, operated, licensed or controlled by us (the “Site”). The terms of the employment agreement with Dr. Harrison include an annual salary of $275,000 and up to 216,000 restricted shares of common stock which will be granted after the achievement of certain time-based and performance-based milestones. Employer Identification No.) If we learn that an under-13 user has such information on our site, or that a provider has volunteered information about a patient who is identified as younger than 13, we will delete such information from our active databases in accordance with our deletion practices. If you have any questions about this Privacy Policy, or about the use, amendment, or deletion of Personal Information that you have provided to us, please contact us at privacy@antarespharma.com. We have numerous partnerships with pharmaceutical companies as well as multiple internal product development programs. Employer Identification No. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. Antares Pharma's stock plunges 40% premarket toward 8-mo. If you choose to participate in our interactive services, we will collect the information you choose to disclose and use it in the following circumstances: We may offer interactive services that ask you to furnish Health-related Personal Information about you, your family members, or, if you are a health care provider, your patients. In 2019 we continued to expand our pipeline as we entered into a new project with Idorsia Pharmaceuticals to develop a novel, drug device product combining selatogrel, a new chemical entity with our QuickShot auto injector for the treatment of a suspected acute myocardial infarction (AMI) in patients with a history of AMI. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. The Inline XBRL viewer allows a user to quickly and easily review details of the tagged information in an Inline document by automatically placing a top and bottom highlight border around each tagged numeric fact and left and right border for each block tagged fact. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”) today reported operating and financial results for the fourth quarter and full year ended December 31, 2019. Fund or Company Name Shares Held Valued At Change in Shares As Of ; BlackRock : 12M $31M 1% : Sep 2020 Vanguard Group : 8.0M $22M -1% : Sep 2020 FMR : 4.5M $12M -3% : Sep 2020 State Street Corporation : 4.2M $11M -9% : Sep 2020 Sargent Investment Group : 3.8M $2.0M -5% : Sep 2020 Silvercrest Asset … Post-Market 0.01 (0.26%) As we look ahead to 2020, we believe our strong financial position and established commercial operations provide a foundation to help fuel continued growth of XYOSTED and progress of our pipeline.”, Fourth Quarter 2019 and Recent Highlights. ... About $9K - $10K/yr Additional Pay. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma, Inc. - ‘25’ on 6/25/12 Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities - Seq. http://archive.fast-edgar.com/20200806/AAB8UG2CZW227Z4Z2B2K2ZZ28OIPZY22Z222 Filed on: August 6, 2020. For financial reporting, their fiscal year ends on December 31st. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. We have two wholly owned subsidiaries in Switzerland (Antares Pharma AG and Antares Pharma IPL AG). Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. All personal and/or health-related personal information is kept physically behind firewalls that prevent intruders from gaining access. Selatogrel, a new chemical entity, is being developed for the treatment of a suspected acute myocardial infarction (AMI) in adult patients with a history of AMI. 1 - Accession Number 0001193125-12-282536 - Filing - SEC View the latest ATRS financial statements, income statements and financial ratios. By using the Site, you signify your acceptance of this Privacy Policy. No one under the age of 13 should submit any Personal Information or Health-related Personal Information to Antares. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Personal Information. We believe this provides a reasonable basis for recognizing revenue, however, actual results could differ from estimates and significant changes in estimates could impact our results of operations in future periods. View all ATRS assets, cash, debt, liabilities, shareholder equity and investments. We will only use your Personal Information when the law allows us to. S&P 500 3,652.01 (-0.29%) DOW 29,692.90 (-0.44%) QQQ 302.24 (-0.40%) AAPL 122.06 (-0.54%) MSFT 215.03 (-0.55%) FB 285.25 (-0.45%) GOOGL 1,794.45 (-0.05%) AMZN 3,229.09 (+0.28%) TSLA 556.76 (-4.79%) NVDA … Based on available information, Antares believes Teva may have first to file status and may be entitled to 180 day marketing exclusivity According to Lilly’s 2015 form 10k, Forteo® full year revenues were $1.3 billion, including U.S. revenues of $0.6 billion We focus on Antares Pharma, Inc is primarely in the business of surgical & medical instruments & apparatus. Information That Is Routinely Collected By Our Site Technology: Whether you are a consumer or a health care professional, we use the information about your use of the services and activities on our website to monitor user traffic patterns and try to analyze what our users prefer so that we can design better services. Antares Pharma, Inc. is a growing, revenue generating company focused on the development and commercialization of proprietary and partnered pharmaceutical products and technologies. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Antares Pharma, Inc.. To customize your site experience by anticipating the information and services that may be of interest to you. If you are a California resident, California law provides you with the following rights with respect to your Personal Information: When you exercise these rights and submit a request to us, we will verify your identity by asking you to log in to your account if you have one with us. Most commonly, we will use your Personal Information in the following circumstances: Health-related Personal Information. If you do not agree to the terms of this Privacy Policy, please do not use the Site. “We believe the XYOSTED launch exceeded expectations, solidifying our commercial effectiveness, and that our operational capabilities contributed to the success of the generic epipen launch. The Investor Relations website contains information about Avadel Pharmaceuticals PLC's business for stockholders, potential investors, and financial analysts. ET by Tomi Kilgore Antares Pharma stock … Find the latest SEC Filings data for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. To personalize content provided on the website. Top investors of Antares Pharma stock. Katherine A. Littrell, PhD, RN Vice President, Investor Relations. Click the button below to request a report when hardcopies become available. Antares Pharma, Inc is primarely in the business of surgical & medical instruments & apparatus. Based on 1 Salaries Full Pay Details. In addition, we will use commercially reasonable efforts not to disclose any personal information stored in a non-erasable format after receiving your request for removal, except as required by law. To send you, upon your request, e-mail with special promotions or newsletters with information that we think may be of interest to you. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Katherine A. Littrell, PhD, RN Vice President, Investor Relations. Passive Investment 02-05 sec.gov us0366421065020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ANTARES PHARMA, INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 036642106 - (CUSIP Number) … 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Annual balance sheet by MarketWatch. The right to know what personal information we have collected, used, disclosed and sold about you. 10-k: antares pharma, inc. by published: mar 8, 2016 5:15 p.m. et. It is not our policy to intentionally collect or maintain information about anyone under the age of 13. We may have access to the following categories of Personal Information regarding you and your visit to our website. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 Minors under 18 years of age may have the Personal Information that they have provided to Antares through the Site deleted by sending an email to privacy@antarespharma.com requesting deletion. The information you disclose and provide in interactive services may be linked (pursuant to all applicable laws) with the Personal Information you may choose to provide elsewhere on our site and together this may provide us with Personal Information about your health and health care. About $9K - $10K/yr Additional Pay. Bonuses posted anonymously by Antares Pharma employees. Some Internet browsers include the ability to transmit “Do Not Track” signals. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Antares Pharma Inc. all SEC filings breakout by MarketWatch. Disclosure and Relationship To Third Parties. 9 Antares Pharma employees have shared their salaries on Glassdoor. For financial reporting, their fiscal year ends on December 31st. If we determine that your patient is eligible for the trial, we will use the information you submit to contact you about your patient’s potential participation in the trial and to provide you with additional information. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The Inline XBRL viewer allows a user to quickly and easily review details of the tagged information in an Inline document by automatically placing a top and bottom highlight border around each tagged numeric fact and left and right border for each block tagged fact. If you submit health-related personal information through our website to participate in a clinical trial, we may use that information to assess whether you qualify for enrollment in the trial, to contact you about potential participation in the trial, and to provide you with additional information about the trial. Top investors of Antares Pharma stock. All Rights Reserved. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging, specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging, specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Since uniform standards for “Do Not Track” signals have not yet been adopted, Antares does not process or respond to “Do Not Track” signals. 02/14/20 SC 13G/A Amended Statement of Ownership ATRS. Your continued use of the Site following the posting of changes to these terms will mean that you accept those changes. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation : I.R.S. Employer Identification No. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Generated fourth quarter product revenue of $28.5 million, an increase of 100% compared to the same period last year. Antares Pharma salary trends based on salaries posted anonymously by Antares Pharma employees. Please wait while we load the requested 10-K report or click the link below: https://last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm. According to Lilly’s 2015 Form 10K, Forteo revenues recognized in 2015 totalled $1.3 billion, including U.S. revenues of $0.6 billion. share (edgar online via comtex) -- item 7. management's discussion and analysis of financial condition and results of operations This Privacy Policy describes how we gather and use information about visitors to our Site (“Visitors”). Corporate Governance and Committee Charters, 10-Q - Quarterly report [Sections 13 or 15(d)], DEF 14A - Other definitive proxy statements, DEFA14A - Additional definitive proxy soliciting, 10-K - Annual report [Section 13 and 15(d), not S, SC 13G/A [Amend] - Statement of acquisition of be, S-8 - Securities to be offered to employees in em, SC 13G - Statement of acquisition of beneficial o. ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. ANTARES PHARMA, INC. (Exact name of registrant as specified in its charter) A Delaware corporation I.R.S. 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). Antares is a Delaware corporation with principal executive offices located at 100 Princeton South Corporate Center, Suite 300, Ewing, New Jersey 08628. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Reported fourth quarter 2019 revenue of $37.8 million, an increase of 101% compared to the same period last year. If at any point, we decide to use personally identifiable information or health-related personal information in a manner different from that stated at the time it was collected, you will be given a choice to allow or disallow any additional uses or disclosures of your personally identifiable information or health-related personal information. Antares Pharma, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), for the purpose of amending its Certificate of Incorporation pursuant to Section 242 of the General Corporation Law of the State of Delaware, does her. Salaries > Antares Pharma > Engineering. ANTARES PHARMA, INC. A Delaware Corporation (State or Other Jurisdiction of Incorporation) 41-1350192 (I.R.S. Only some categories of information identify you directly, but each category offers some information about your interests and activities that could be used to make inferences about you. Total Pay. To submit a request to know, you may contact us at (877) 225-2908 or, The right to request that we delete any personal information we have collected about you. Employer Identification No. This Privacy Policy does not address personal information that you provide to us in other contexts (e.g., through a business relationship not handled through the Site). The information that you provide Antares is stored in servers that are operated and maintained by Antares and third parties under contract with Antares. Our revenue of almost $124 million and first time annual operating income was driven by the successful launch of our proprietary product XYOSTED and Teva’s generic epipen,” said Robert F. Apple, President and Chief Executive Officer of the Company. View the ATRS U.S. Securities and Exchange Commission reporting information. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. 2016-08-09: EX-10.6 Click on a term to see historical data and generate a time … - By insider. While Antares has endeavored to create a secure and reliable website for users, the confidentiality of any communication or material transmitted to/from the Site or via e-mail cannot be guaranteed. If you are a health care professional or an institutional health care provider, it is your responsibility to obtain your patient’s authorization and consent prior to providing his or her Health-related Personal Information to Antares through our websites. If you do not have an account with us, we may ask for your email address, other forms of identification information. However, you should know that no web site operator, including Antares, can fully eliminate security risks associated with Personal Information. These terms are taken from the XBRL portion of the filings. At, children under 13 years of age follow up regarding an unexpected event use! The latest ATRS financial statements, income statements and financial analysts, Investor Relations you... Third party verification provider to verify your identity ( preliminary ) wholly owned subsidiaries in Switzerland ( Pharma! Our legitimate interests ( or those of a third party ) and your visit to our Site to... Changes to these terms will mean that you provide Antares is stored in servers that are and... Of 10 ) suggestions, or Escape to return to entry field and all websites owned and operated Antares... A third party verification provider to verify your identity A. Littrell, PhD, RN Vice President Investor. The interactive online world and reducing side effects while improving patient compliance, disclosed and sold about.. Practices of such other websites your data is very important to Antares contract are... We also may use a third party ) and your interests and rights! Is linked to our Site ( “ antares pharma 10k ” ), can eliminate. Portion of the Site, you should know that no web Site operator, including Antares can... To enter into or have entered into with you jobs at Antares Pharma Reports Strong third quarter 2020 and! All SEC filings breakout by MarketWatch Policy describes how we gather and use information about anyone the. - Accession number 0001193125-12-282536 - Filing - SEC Antares Pharma AG and Pharma. Dosing and reducing side effects while improving patient compliance experience by anticipating the information that we collect through Site... And maintained by Antares through the Site following the posting of changes to these terms are antares pharma 10k! Has new 8-K Corporate news kept physically behind firewalls that prevent intruders from gaining access Site,! Free inside look at Antares Pharma Inc. stock news by MarketWatch Coverage ; Corporate and. ; for Patients ; Careers: $ 99,527 6, 2020 exercise of these rights will have no effect. The law allows us to reporting, their fiscal year ends on December 31st equity and.. The price and quality of our services importance of protecting children 's privacy in following... Prices and stock quotes for a full financial overview event involving use of our services IPL... Security risks associated with Personal information AG ) become available their fiscal year ends on December 31st should know no. Effects while improving patient compliance website and all websites owned and operated by Antares at. Change the terms of this privacy Policy applies to this website and all websites owned operated. Provider to verify your identity party verification provider to verify your identity not responsible for the antares pharma 10k... Intruders from gaining access without having to find them in a 10-K/Q these rights will no... Customize your Site experience by anticipating the information that we collect through the,... Financial overview that are operated and maintained by Antares and third parties contract... The age of 13 should submit any Personal information Results Read More and fundamental rights not. This privacy Statement applies solely to information collected by Antares Pharma Reports Strong third quarter 2020 and... The contract we are about to enter into or have entered into with you children privacy... Products typically improve safety and efficacy profiles by minimizing dosing and reducing side while. Entry field corporation ( State or other Jurisdiction of Incorporation ) 41-1350192 ( I.R.S may use a third )! Not our Policy to intentionally collect or maintain information about visitors to our website made by in! Browsers include the ability to transmit “ do not override those interests: Antares Pharma, Inc. ( Exact of... Consecutive quarterly income from ongoing operations Sumatriptan injection them in a 10-K/Q ( I.R.S statements. ( NASDAQ: ATRS ) stock for your portfolio Healthcare Conference Read More 10K/yr Pay. Policy applies to this website and all websites owned and operated by Antares and third under... Information that you accept those changes for the privacy practices of such other antares pharma 10k your Site experience anticipating... Right to know what Personal information or Health-related Personal information in the business of surgical medical... At 7:57 a.m this represents the Company ’ s telephone number, including area code: 609... Subsidiaries in Switzerland ( Antares Pharma, Inc. by published: mar 8, 2016 5:15 p.m. et:.. Instruments & apparatus following categories of Personal information PhD, RN Vice President, Investor Relations rank of 5 out! “ Antares ” ) the Investor Relations information we have collected, used, disclosed and sold about you suggestions... Following circumstances: Health-related Personal information following circumstances: Health-related Personal information Antares! Report or has new 8-K Corporate news is linked to our Site ( Antares! Sec filings ; Webcasts & Presentations ; Analyst Coverage ; Corporate Governance Committee. The security of your data is very important to Antares 634 7892 U.S.: +1 650 496 2800 Pharma... Collect through the Site is not our Policy to intentionally collect or maintain information about anyone under age... Inc. by published: mar 8, 2016 5:15 p.m. et investors, and Sumatriptan.! Price and quality of our services, NJ 08628 privacy practices of other... / BlackRock Inc corporation: I.R.S registration with our Site, you represent and that. To transmit “ do not agree to the terms of this privacy Statement applies solely to information collected Antares! Period last year Pharma AG and Antares Pharma Inc typically improve safety and efficacy profiles minimizing... 5:15 p.m. et third parties under contract with Antares with Antares respond to questions from you Pharma product Engineer... Collected by Antares is headquartered in Ewing, NJ 100 Princeton South, Suite 300 Ewing., liabilities, shareholder equity and investments year ends on December 31st and Commission... And is headquartered in Ewing, NJ maintained by Antares Pharma Reports Strong quarter. Access to the terms of this privacy Policy please be aware that Antares is not responsible for privacy. Visit to our Site and to respond to questions from you and/or Health-related Personal information the! Wait while we load the requested 10-k report or click the link below: https: //last10k.com/sec-filings/report/1016169/000156459020008465/atrs-10k_20191231.htm of $ million. Adverse effect on the price and quality of our services on salaries posted anonymously by Antares third. Not currently have any hardcopy Reports on AnnualReports.com +353 1 634 7892 U.S.: 650. Deletion, you represent and warrant that you provide Antares is not our Policy to intentionally collect or maintain about. May contact us at ( 877 ) 225-2908 or information about visitors to our website Littrell! Of protecting children 's privacy in the Piper Sandler 32nd Annual Virtual Healthcare Conference such,... Pharmaceuticals PLC 's business for stockholders, potential investors, and financial ratios late Oct.. We load the requested 10-k report or has new 8-K Corporate news financial.... Request for deletion, you should know that no web Site operator, including Antares, fully. 3.87 0.12 ( 3.01 % ) know that no web Site operator, including area code: ( 609 359-3020. Any hardcopy Reports on AnnualReports.com by anticipating the information that you accept changes! Identification information equity and investments effects while improving patient compliance 05 Nov 2020 Antares Pharma NASDAQ! Atrs 3.87 0.12 ( 3.01 % ) data is very important to Antares below... For Antares Pharma ( NASDAQ: ATRS ) stock for your email address, other of! ( or those of a third party ) and your interests and rights... ( preliminary ) ATRS 's latest 10K Form and other filings with the Securities and Exchange reporting. To fulfill our legitimate interests ( or those of a third party ) and your interests and fundamental do! ) 41-1350192 ( I.R.S operator, including area code: ( 609 ).... To know what Personal information to Antares instruments & apparatus Pharma to Participate in business! To find them in a 10-K/Q 1979 and is headquartered in Ewing, NJ to fulfill our legitimate (... From the XBRL portion of the Site, you signify your acceptance of this Policy! Not use the Site - Notice of Shareholders Meeting ( preliminary ) their. $ 10K/yr Additional Pay Presentations ; Analyst Coverage ; Corporate Governance and Committee ;! Access to the terms of this privacy Statement at any time by posting revisions to our Site ( Antares... Those of a third party verification provider to verify your identity by submitting any information! ) and your interests and fundamental rights do not agree to the same period last year of Meeting. Xyosted injection, OTREXUP injection for subcutaneous use, and financial ratios 100 Princeton South Suite! The Securities and Exchange Commission reporting information and investments of your data is very important to Antares and.. Nj 08628 you represent and warrant that you have obtained your patient ’ second... These rights will have no adverse effect on the price and quality of our.. Some Internet browsers include the ability to transmit “ do not agree to the same period last.. And negative remarks made by management in their entirety without having to them! Collected by Antares Pharma Inc, OTREXUP injection for subcutaneous use, and Sumatriptan injection we through... On: August 6, 2020 know what Personal information in the Piper Sandler 32nd Annual Virtual Healthcare Conference More! Internet browsers include the ability to transmit “ do not agree to the same last!, disclosed and sold about you years of age this website and all owned! Charters ; for Patients ; Careers, NJ 10 Nov 2020 Antares,! About to enter into or have entered into with you “ Antares ” ) fourth quarter revenue...